Archived Story

Making mRNA COVID-19 vaccines is hard, but deploying them is harder

primary article image

PermaLink

Sarah Zhang

The Atlantic

Related: @EricTopol

Top News

Johnson & Johnson to resume COVID-19 vaccine clinical trial, following recommendation from independent safety committee and consultation with US FDA

primary article image

PermaLink

Staff Writer

Johnson & Johnson

Related: NBC, STAT

FDA reportedly given green light to resume AstraZeneca/Oxford Covid-19 vaccine trial in US

primary article image

PermaLink

Thomas M. Burton

Wall Street Journal


One volunteer in the clinical trial of AstraZeneca's Covid-19 vaccine in Brazil dies. The safety committee confirmed no safety risk and the clinical trial may continue

primary article image

PermaLink

Staff Writer

Bloomberg

Related: Sky News, Wall Street Journal

WSJ reports story behind the deal of Oxford- AstraZeneca Covid-19 vaccine

primary article image

PermaLink

Jenny Strasburg

Wall Street Journal


CRISPR Therapeutics reports a patient death in phase 1 clinical trial of its allogeneic CAR-T cell therapy for lymphoma, yet clear, dose-dependent anti-tumor activity observed in this study

primary article image

PermaLink

Staff Writer

CRISPR Therapeutics

Related: InvestorPlace

UK to launch the world's first human challenge trial - to infect healthy volunteers with coronavirus: first to test the minimal amount of virus needed to cause disease, then to test if vaccine can provide protection

primary article image

PermaLink

Staff Writer

BBC

Related: Nature, The Washington Post

Moderna to have interim results of its Covid-19 vaccine clinical trial in November

primary article image

PermaLink

Peter Loftus

Wall Street Journal

Related: Boston Globe

‘Circuit breakers’ or ‘firebreaks’? UK tries different ways of lockdown to battle worsening coronavirus endemic

primary article image

PermaLink

Max Stephens

The Telegraph - London

Related: YouTube, CNBC

Pfizer to apply for Emergency Authorization Use in US in the 3rd week November if its Covid-19 vaccine proven effective, safe, able to be produced consistently at the highest quality standards

primary article image

PermaLink

Staff Writer

pfizer

Related: Fox Business

Sinovac's Covid-19 vaccine offered to China's city Jiaxin for emergency use at costs of $60. The Company plans to start clinical trial in Philippines in November

primary article image

PermaLink

Reuters Staff

Reuters

Related: yahoo

Johnson & Johnson halts its Covid-19 vaccine clinical trial of 60K participants due to due to “an unexplained illness in a study participant.” The data and safety monitoring board convened later today to review the case

primary article image

PermaLink

Matthew Herper

STAT

Related: Johnson & Johnson, CNN

Operation Warp Speed Chief expects the first EUA application for Covid-19 vaccine by late November, then have enough doses to vaccine 80M to 100M people by January

primary article image

PermaLink

Sa Editor Yoel Minkoff

Seeking Alpha

Related: Wall Street Journal, Business Insider

Spain declares state of emergency in Madrid to fight re-surging coronavirus

primary article image

PermaLink

Staff Writer

yahoo

Related: BBC

China joins WHO-backed global Covid-19 vaccine distribution program COVAX, while US and Russia remain outside of this program

primary article image

PermaLink

Colin Qian

Reuters

Related: South China Morning Post

Regeneron also seeks FDA emergency authorization of its Covid-19 dual antibody cocktail treatment. President praised the drug in a video and pledged free of charge for Americans

primary article image

PermaLink

Katie Thomas

New York Times

Related: @realDonaldTrump, Reuters

Eli Lilly seeks FDA emergency authorization of its Covid-19 monoclonal antibody treatment LY-CoV555. The drug found to reduce the rate of hospitalizations for coronavirus patients when used alone or combined with another antibody drug LY-CoV016

primary article image

PermaLink

Noah Higgins-Dunn

CNBC

Related: @ScottGottliebMD, Wall Street Journal, STAT

2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier and Jennifer Doudna, inventors of the gene editing, aka CRISPR technology

primary article image

PermaLink

Jon Cohen

Science

Related: The Nobel Committee for Physiology or Medicine, NPR - National Public Radio

European Medicines Agency starts "rolling review" Pfizer-BioNTech COVID-19 vaccine clinical trial data to speed up the evaluation process. EMA also started the same review process on Oxford-AstraZeneca's Covid-19 vaccine data

primary article image

PermaLink

Reuters Staff

Reuters

Related: European Medicines Agency (EMA)

The 2020 Nobel Prize in Physiology or Medicine awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C virus

primary article image

PermaLink

Staff Writer

The Nobel Committee for Physiology or Medicine

Related: CNN

BMS to buy heart drug developer MyoKardia with $13.1 Billion to boost cardiovascular pipeline. MyoKardia soon to file for FDA approval of Mavacamten for treating hypertrophic cardiomyopathy

primary article image

PermaLink

Jared S. Hopkins

Wall Street Journal

Related: Bloomberg

Latest News

Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.

24 Oct 2020, 3:21 AM, Staff Writer, Johnson & Johnson


AstraZeneca, Johnson & Johnson resume late-stage Covid-19 vaccine trials

23 Oct 2020, 8:28 PM, Erika Edwards, NBC


Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S.

23 Oct 2020, 7:23 PM, Thomas M. Burton, Wall Street Journal


Covid-19 vaccine trials from AstraZeneca, Johnson & Johnson to restart

23 Oct 2020, Matthew Herper, STAT


Coronavirus: Oxford vaccine trial will continue in Brazil after death of volunteer who took placebo

21 Oct 2020, 9:44 PM, Staff Writer, Sky News


AstraZeneca/Oxford Coronavirus Vaccine Trial in Brazil to Continue Following Death of Volunteer

21 Oct 2020, 9:39 PM, Luciana Magalhaes, Wall Street Journal


Oxford Developed Covid Vaccine, Then Scholars Clashed Over Money

21 Oct 2020, 9:21 PM, Jenny Strasburg, Wall Street Journal


CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell Malignancies

21 Oct 2020, 3:47 PM, Staff Writer, CRISPR Therapeutics


Deceased AstraZeneca Trial Volunteer Didn’t Receive Vaccine

21 Oct 2020, Staff Writer, Bloomberg


Moderna CEO Expects Covid-19 Vaccine Interim Results in November

20 Oct 2020, 1:39 PM, Peter Loftus, Wall Street Journal


Dozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials

20 Oct 2020, 1:34 PM, Ewen Callaway, Nature


UK plan to be first to run human challenge Covid trials

20 Oct 2020, 1:29 PM, Staff Writer, BBC


COVID-19 UK: Two thirds of British people support national ‘circuit breaker’ lockdown

20 Oct 2020, 1:14 PM, Sky News YouTube Channel, YouTube


Moderna CEO say its COVID-19 vaccine could get emergency-use OK in December

20 Oct 2020, Staff Writer, Boston Globe


Will England go into a 'circuit breaker' lockdown?

20 Oct 2020, Max Stephens, The Telegraph - London


Britain to infect healthy volunteers with coronavirus in vaccine challenge trials

20 Oct 2020, William Booth, The Washington Post


Coronavirus 'circuit breakers' and 'firebreaks:' What are they and do they work?

20 Oct 2020, Holly Ellyatt, CNBC


Stock futures gain on coronavirus vaccine progress, retail growth

16 Oct 2020, 1:32 PM, Jonathan Garber, Fox Business


An Open Letter from Pfizer Chairman and CEO Albert Bourla

16 Oct 2020, 1:16 PM, Staff Writer, pfizer


Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60

16 Oct 2020, 6:49 AM, Reuters Staff, Reuters